Skip to Content

M CL2 (Carbidopa and Levodopa 25 mg / 100mg)

Pill with imprint M CL2 is Yellow, Round and has been identified as Carbidopa and Levodopa 25 mg / 100mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M CL2

Carbidopa and Levodopa

Imprint
M CL2
Strength
25 mg / 100mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
crospovidone, hydroxypropyl cellulose (type h), magnesium stearate, microcrystalline cellulose, corn starch, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-0085 Mylan Pharmaceuticals Inc.
51079-0884 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M CL2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.